Shree Ganesh Remedies Limited (BOM:540737)
India · Delayed Price · Currency is INR 649.35
+1.10 (0.17%)
At close: May 29, 2026
Shree Ganesh Remedies Revenue
In the fiscal year ending March 31, 2026, Shree Ganesh Remedies had annual revenue of 1.09B INR with 0.63% growth. Shree Ganesh Remedies had revenue of 331.96M in the quarter ending March 31, 2026, with 35.87% growth.
Revenue
1.09B
Revenue Growth
+0.63%
P/S Ratio
7.63
Revenue / Employee
7.33M
Employees
149
Market Cap
8.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.09B | 6.89M | 0.63% |
| Mar 31, 2025 | 1.09B | -172.99M | -13.74% |
| Mar 31, 2024 | 1.26B | 356.76M | 39.54% |
| Mar 31, 2023 | 902.20M | 189.32M | 26.56% |
| Mar 31, 2022 | 712.88M | 222.06M | 45.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 23.19B |
| Bajaj HealthCare | 6.11B |
| NGL Fine-Chem | 5.01B |
| Aarey Drugs & Pharmaceuticals | 4.78B |
| Sai Parenteral's | 3.81B |
| Anlon Healthcare | 1.72B |
| Influx Healthtech | 1.47B |
| Kimia Biosciences | 1.17B |
Shree Ganesh Remedies News
- 1 year ago - Shree Ganesh Remedies shares tumble over 8% after Q4 net profit drops 48% YoY - Business Upturn
- 1 year ago - Shree Ganesh Remedies commissions 2.5 MW solar power project, expects Rs 2 crore annual savings - Business Upturn